{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/420913397"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Acceleron Pharma (XLRN) is developing medicines that play a role in the growth and repair of cells and tissues, such as red blood cells, bone and blood vessels, that are targeted for use in treating blood diseases and cancer." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "investors.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/177938561"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/420913397" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/308723568"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/420913397" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/309411619"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/420913397" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/393608257"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/420913397"] } } }
